AVTR · Avantor, Inc.

$13.66 -0.19 (-1.37%) At close · Aug 14

Market Cap

$9.33B

682.76M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Former Chief Executive Officer	$1,140,000	—	$8,125,784	$2,749,997	$1,022,795	$39,355	$13,077,931
Brent Jones	CFO	$653,269	—	$4,823,755	$749,999	$272,288	$39,355	$6,538,667
R. Brent Jones	Executive Vice President and Chief Financial Officer	$653,269	—	$4,823,755	$749,999	$272,288	$39,355	$6,538,667
Corey Walker	President Laboratory Solutions	$700,000	—	$4,173,757	$749,999	$322,755	$41,305	$5,987,816
Emmanuel Ligner	Director, President and Chief Executive Officer	$379,297	—	$2,499,990	$2,499,998	$330,038	$186,301	$5,895,624
Benoit Gourdier	Executive Vice President Bioscience Production	$550,000	—	$3,804,417	$624,999	$215,921	$30,082	$5,225,419
Claudius Sokenu	Executive Vice President, Chief Legal and Compliance Officer	$550,000	—	$2,576,284	$375,000	$208,317	$40,312	$3,749,913

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Former Chief Executive Officer	$1,126,846	—	$8,651,135	$2,625,038	$2,085,069	$37,550	$14,525,638
Brent Jones	CFO	$611,519	—	$2,059,777	$625,020	$554,220	$35,915	$3,886,451
R. Brent Jones	Executive Vice President and Chief Financial Officer	$611,519	—	$2,059,777	$625,020	$554,220	$35,915	$3,886,451
Benoit Gourdier	Executive Vice President Bioscience Production	$516,057	—	$2,059,777	$625,020	$512,210	$20,000	$3,733,064
Claudius Sokenu	Executive Vice President, Chief Legal and Compliance Officer	$543,654	—	$1,400,628	$425,033	$431,739	$31,804	$2,832,857

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Director, President and Chief Executive Officer	$1,140,000	—	$8,529,219	$2,437,053	$188,100	$36,500	$12,338,767
Brent Jones	CFO	$221,154	$200,000	$2,817,998	$2,561,102	$18,526	$22,015	$5,840,795
R. Brent Jones	Executive Vice President and Chief Financial Officer	$221,154	$200,000	$2,817,998	$2,561,102	$18,526	$22,015	$5,840,795
Randy Stone	Executive Vice President	$415,385	—	$2,105,342	$1,999,997	$34,192	$33,200	$4,588,116
Frederic Vanderhaegen	Executive Vice President Europe	$618,212	—	$1,749,559	$499,925	$52,761	$122,895	$3,043,353
Gerard Brophy	Former Executive Vice President,	$575,000	—	$1,749,559	$499,925	$46,000	$29,231	$2,907,627
Thomas Szlosek	Former Executive Vice President and Chief Financial Officer	$369,231	—	$1,924,529	$549,903	—	$33,200	$2,882,892
James Bramwell	Executive Vice President, Americas	$497,981	—	$1,749,559	$499,925	$39,384	$33,650	$2,840,235

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Director, President and Chief Executive Officer	$1,127,308	—	$7,371,470	$2,313,486	—	$19,502	$10,831,766
Thomas Szlosek	Former Executive Vice President and Chief Financial Officer	$600,000	—	$1,753,183	$550,255	—	$16,586	$2,923,808
Frederic Vanderhaegen	Executive Vice President Europe	$577,652	—	$1,593,803	$500,229	—	$88,467	$2,760,151
Gerard Brophy	Former Executive Vice President,	$563,462	—	$1,593,803	$500,229	—	$16,006	$2,676,620
Sheri Lewis	Executive Vice President, Global Operations & Supply Chain	$475,000	—	$1,036,025	$325,101	—	$15,618	$1,851,744

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Director, President and Chief Executive Officer	$1,085,000	—	$6,633,149	$2,000,000	$3,523,212	$14,210	$13,260,913
Thomas Szlosek	Former Executive Vice President and Chief Financial Officer	$600,000	—	$1,492,479	$449,998	$1,771,200	$16,674	$4,335,943
Frederic Vanderhaegen	Executive Vice President Europe	$579,674	—	$1,492,479	$449,998	$962,718	$80,238	$3,565,108
Biopharma Production	—	$513,462	—	$1,492,479	$449,998	$862,406	$15,018	$3,338,920
Gerard Brophy	Executive Vice President	$513,462	—	$1,492,479	$449,998	$862,406	$15,018	$3,338,920
Sheri Lewis	Executive Vice President, Global Operations & Supply Chain	$469,519	$250,000	$1,243,687	$375,000	$560,880	$14,887	$2,913,973

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Director, President and Chief Executive Officer	$1,085,000	—	$4,813,959	$2,499,998	$2,372,081	$479,752	$11,257,062
Thomas Szlosek	Executive Vice President and Chief Financial Officer	$600,000	—	$2,405,359	$1,849,997	$1,371,275	$11,400	$6,243,778
Frederic Vanderhaegen	Executive Vice President Europe	$495,457	—	$1,962,814	$1,500,000	$615,451	$64,289	$4,638,011
Biopharma Production	—	$474,693	—	$1,834,438	$1,433,330	$519,234	$11,400	$4,278,996
Gerard Brophy	Executive Vice President	$474,693	—	$1,834,438	$1,433,330	$519,234	$11,400	$4,278,996
Michael Wondrasch	Executive Vice President,Chief Information Officer	$399,731	—	$1,327,669	$1,050,004	$397,500	$11,400	$3,192,367

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Michael Stubblefield	Director, President and Chief Executive Officer	$984,308	$130,000	$14,000,000	—	$1,282,296	$593,526	$16,995,265
Ashish Kulkarni	Executive Vice President and Chief Technology Officer	$400,000	$737,000	$1,799,994	—	—	$2,126,062	$5,068,233
Thomas Szlosek	Executive Vice President and Chief FinancialOfficer	$600,000	—	$2,599,996	—	$765,000	$11,200	$3,977,065
Devashish Ohri	Executive Vice President, IMEA	$366,807	—	$2,200,002	—	$92,087	$633,423	$3,292,319

Executive changes

Person	Role	Change	Effective	Filed
Ludovic Brellier	Executive Vice President, Bioscience and Medtech Products and Chief Transformation Officer	Appointed	2026-05-01	2026-04-23
R. Brent Jones	Executive Vice President and Chief Financial Officer	Resigned	—	2026-04-01
Jonathan Peacock	director	Resigned	2025-12-31	2025-12-18
Simon Dingemans	director	Appointed	2026-01-02	2025-12-18
Sanjeev Mehra	director	Appointed	2025-12-04	2025-12-04
Gregory Lucier	director	Appointed	2025-10-01	2025-11-10
Gregory Lucier	director	Appointed	2025-10-03	2025-10-03
Emmanuel Ligner	director	Appointed	2025-08-18	2025-08-13
Emmanuel Ligner	President and Chief Executive Officer	Appointed	2025-08-18	2025-07-21
Mala Murthy	director	Appointed	—	2025-05-12
Michael Stubblefield	director	Appointed	—	2025-05-12
Gregory Summe	director	Appointed	—	2025-05-12
Michael Severino	director	Appointed	—	2025-05-12
Jonathan Peacock	director	Appointed	—	2025-05-12
Louise Makin	director	Appointed	—	2025-05-12
Joseph Massaro	director	Appointed	—	2025-05-12
Lan Kang	director	Appointed	—	2025-05-12
John Carethers	director	Appointed	—	2025-05-12
Juan Andres	director	Appointed	—	2025-05-12
Dame Louise Makin DBE	director	Appointed	2024-11-04	2024-11-06
Corey Walker	President, Laboratory Solutions	Appointed	2024-06-21	2024-06-21
Randy Stone	Executive Vice President, Laboratory Solutions	Terminated	2024-06-30	2024-06-21
Dr. Gerard Brophy	chair of the Company's Scientific Advisory Board	Appointed	2024-04-03	2024-04-05
Dr. Gerard Brophy	Executive Vice President, Biopharma Production	Retired	2024-02-29	2023-09-26
R. Brent Jones	Executive Vice President and Chief Financial Officer	Appointed	2023-08-07	2023-07-13

Key facts CIK 1722482 CUSIP 05352A100 13F (30d) 454 filings 428 filers Visit website Investor relations